| CTRI Number |
CTRI/2025/03/082994 [Registered on: 20/03/2025] Trial Registered Prospectively |
| Last Modified On: |
03/03/2025 |
| Post Graduate Thesis |
Yes |
| Type of Trial |
Observational |
|
Type of Study
|
Ambispective descriptional |
| Study Design |
Single Arm Study |
|
Public Title of Study
|
Outcomes in the mother and newborn in pregnant patients having portal hypertension. |
|
Scientific Title of Study
|
Maternal and Fetal outcome in pregnancies complicated by portal hypertension. An observational study. |
| Trial Acronym |
nil |
|
Secondary IDs if Any
|
| Secondary ID |
Identifier |
| NIL |
NIL |
|
|
Details of Principal Investigator or overall Trial Coordinator (multi-center study)
|
| Name |
Dr Bodicherla Bhuvana Sai |
| Designation |
Junior resident |
| Affiliation |
JIPMER |
| Address |
Department of obstetrics and gynaecology
Women and childrens hospital
Pondicherry PONDICHERRY 605006 India |
| Phone |
8309488351 |
| Fax |
|
| Email |
bvnsai0601@gmail.com |
|
Details of Contact Person Scientific Query
|
| Name |
Dr Dilip Kumar Maurya |
| Designation |
Professor |
| Affiliation |
JIPMER |
| Address |
Department of obstetrics and gynaecology
Women and childrens hospital
JIPMER
PONDICHERRY 605006 India |
| Phone |
9442136037 |
| Fax |
|
| Email |
dilipkm2@gmail.com |
|
Details of Contact Person Public Query
|
| Name |
Dr Bodicherla Bhuvana Sai |
| Designation |
Junior resident |
| Affiliation |
JIPMER |
| Address |
Department of obstetrics and gynaecology
Women and childrens hospital
JIPMER
PONDICHERRY 605006 India |
| Phone |
8309488351 |
| Fax |
|
| Email |
bvnsai0601@gmail.com |
|
|
Source of Monetary or Material Support
|
| Jawaharlal Institute of Postgraduate Medical Education and Research
Gorimedu, Dhanvantari Nagar, Puducherry, India
605006. |
|
|
Primary Sponsor
|
| Name |
Jawaharlal Institute of Postgraduate Medical Education and Research |
| Address |
Jawaharlal Institute of Postgraduate Medical Education and Research
Gorimedu,
Dhanvantari Nagar,
Puducherry, India
605006.
|
| Type of Sponsor |
Research institution and hospital |
|
|
Details of Secondary Sponsor
|
|
|
Countries of Recruitment
|
India |
|
Sites of Study
|
| No of Sites = 1 |
| Name of Principal
Investigator |
Name of Site |
Site Address |
Phone/Fax/Email |
| Dr Bodicherla Bhuvana Sai |
Jawaharlal Institute of Postgraduate Medical Education and Research |
Department of obstetrics and gynaecology
Antenatal ward, ICU and HDU
Women and children hospital. Pondicherry PONDICHERRY |
8309488351
jr8415@jipmer.ac.in |
|
|
Details of Ethics Committee
|
| No of Ethics Committees= 1 |
| Name of Committee |
Approval Status |
| Institutional ethics committee for observational studies |
Approved |
|
|
Regulatory Clearance Status from DCGI
|
|
|
Health Condition / Problems Studied
|
| Health Type |
Condition |
| Patients |
(1) ICD-10 Condition: K766||Portal hypertension, |
|
|
Intervention / Comparator Agent
|
|
|
Inclusion Criteria
|
| Age From |
18.00 Year(s) |
| Age To |
50.00 Year(s) |
| Gender |
Female |
| Details |
Portal hypertension diagnosed before or during pregnancy, irrespective of the cause |
|
| ExclusionCriteria |
| Details |
1. Age < 18 years |
|
|
Method of Generating Random Sequence
|
|
|
Method of Concealment
|
|
|
Blinding/Masking
|
|
|
Primary Outcome
|
| Outcome |
TimePoints |
| To assess the maternal and fetal outcomes in pregnancies complicated by portal hypertension |
Outcomes are assessed after delivery. |
|
|
Secondary Outcome
|
| Outcome |
TimePoints |
1. To compare the pregnancy outcome in women with cirrhotic, non-cirrhotic portal fibrosis (NCPF) & extrahepatic portal vein obstruction (EHPVO).
2. To assess the risk factors associated with variceal bleeding during pregnancies, among women with portal hypertension. |
Outcomes are assessed after delivery. |
|
|
Target Sample Size
|
Total Sample Size="150" Sample Size from India="150"
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" |
|
Phase of Trial
|
N/A |
|
Date of First Enrollment (India)
|
22/03/2025 |
| Date of Study Completion (India) |
Applicable only for Completed/Terminated trials |
| Date of First Enrollment (Global) |
Date Missing |
| Date of Study Completion (Global) |
Applicable only for Completed/Terminated trials |
|
Estimated Duration of Trial
|
Years="2" Months="6" Days="0" |
|
Recruitment Status of Trial (Global)
|
Not Yet Recruiting |
| Recruitment Status of Trial (India) |
Not Yet Recruiting |
|
Publication Details
|
N/A |
|
Individual Participant Data (IPD) Sharing Statement
|
Will individual participant data (IPD) be shared publicly (including data dictionaries)?
Response - NO
|
|
Brief Summary
|
Pregnant women with a diagnosis of portal hypertension, based on a history
of GI bleed, jaundice, and ascites, presence of varices on endoscopy, presence
of collaterals in spleno-portal axis and dilated portal vein, i.e., more than
13 mm on Doppler ultrasound8, will be identified from the admission
records of the labour ward, antenatal wards, HDU, and the Obstetric Intensive
Care Unit. Details of those who had undergone a portosystemic shunt surgery
with/without splenectomy for portal hypertension and its complications will be
recorded. The cause of portal hypertension will be recorded as – Cirrhotic or
Non-cirrhotic. The non-cirrhotic will be further categorized into NCPF and
EHPVO. If the cause of cirrhosis is
known that also will be collected.
Demographic details including age during
pregnancy, parity, age at the time of diagnosis, clinical details such as
etiology of portal hypertension, duration and course of the disease and
management including medication, endoscopic findings, details of endoscopic or
open surgery, sclerotherapy and the treatment received during pregnancy will be
recorded. Medical complications like hematemesis, any massive bleed, anemia,
severe thrombocytopenia, need for blood products, or any decompensation of
hepatic function (clinical and/ or biochemical), obstetric complications during
pregnancy including abortions, antepartum hemorrhage, hypertensive disorder of
pregnancy and fetal growth restriction; the timing and mode of delivery, any
peripartum complications such as postpartum hemorrhage, and the neonatal
outcomes like birth weight, neonatal intensive care unit (NICU) admissions and
deaths will be collected and analysed. The details of any complications till
discharge form the hospital will be recorded. |